Promoting Organizational Capacity to Implement Cancer Control Programs Among Latino Churches (CRUZA)
This research study aims to develop an organizational-level intervention to enable communities to adopt, adapt, implement and sustain evidence-based interventions (EBIs) to address cancer disparities among Latinos. The investigators partner with faith-based organizations, since they play a highly prominent role in Latino community life. This three-phase study will: (1) improve understanding of the organizational infrastructure, skills and resources required by Latino churches to implement EBIs for cancer control, (2) develop a capacity-building intervention; and (3) test the intervention's effectiveness in a randomized trial.
|Study Design:||Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
|Official Title:||Promoting the Utilization of Cancer Early Detection Methods Among Latinos in Church: a Faith-based Approach|
- Implementation [ Time Frame: 3-months ] [ Designated as safety issue: No ]Number and types of interventions offered
|Study Start Date:||September 2011|
|Estimated Study Completion Date:||September 2013|
|Estimated Primary Completion Date:||September 2013 (Final data collection date for primary outcome measure)|
|Experimental: Capacity Enhancement||
Behavioral: Capacity Enhancement
Churches in the Capacity Enhancement intervention will be invited to work with CRUZA staff over the course of a three month intervention to implement health promotion activities in their church and participate in capacity-building educational workshops. Participants may also receive technical assistance from Health Educators in order to implement their cancer education activities.
|Experimental: Standard Dissemination||
Behavioral: Standard Dissemination
Churches in the Standard Dissemination arm will receive program materials with information about cancer prevention/early detection and health resources.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01740219
|United States, Massachusetts|
|Dana-Farber Cancer Institute|
|Boston, Massachusetts, United States, 02215|
|University of Massachusetts Boston|
|Boston, Massachusetts, United States, 02125|
|Principal Investigator:||Jennifer D Allen, ScD||Dana-Farber Cancer Institute|
|Principal Investigator:||Maria Idali Torres, PhD||University of Massachusetts, Boston|